0001209191-14-075578.txt : 20141215 0001209191-14-075578.hdr.sgml : 20141215 20141215214945 ACCESSION NUMBER: 0001209191-14-075578 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141211 FILED AS OF DATE: 20141215 DATE AS OF CHANGE: 20141215 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO BIOSCIENCES INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANPHIER EDWARD O II CENTRAL INDEX KEY: 0001234386 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30171 FILM NUMBER: 141288238 MAIL ADDRESS: STREET 1: C/O SANGAMO BIOSCIENCES IN STE.A-100 STREET 2: POINT RICHMOND TECH CENTER 501 CANA BLVD CITY: RICHMOND STATE: CA ZIP: 94804 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-12-11 0 0001001233 SANGAMO BIOSCIENCES INC SGMO 0001234386 LANPHIER EDWARD O II C/O SANGAMO BIOSCIENCES INC., POINT RICHMOND TECH CNTR, 501 CANAL BLVD RICHMOND CA 94804 1 1 0 0 President & CEO Common Stock 2014-12-11 4 A 0 125000 0.00 A 420000 D Common Stock 2014-12-15 4 F 0 96533 14.7382 D 323467 D Common Stock 2014-12-15 4 M 0 25000 4.11 A 348467 D Common Stock 2014-12-15 4 S 0 9000 16.4706 D 339467 D Common Stock 2014-12-15 4 S 0 16000 14.7923 D 323467 D Common Stock 1516054 I By Trust Employee Stock Option (Right to Buy) 14.07 2014-12-11 4 A 0 250000 0.00 A 2024-12-10 Common Stock 250000 250000 D Employee Stock Option (Right to Buy) 4.11 2014-12-15 4 M 0 25000 0.00 D 2015-12-11 Common Stock 25000 0 D Shares subject to restricted stock units ("RSUs"), which will vest in a series of three successive equal annual installments upon the Reporting Person's completion of each year of service over the three year period from the grant date. Includes 60,000 and 50,000 shares subject to RSUs granted on December 6, 2012 and December 12, 2013, respectively, that will be issued as such units vest in accordance with their terms. Represents shares withheld to satisfy the Reporting Person's tax withholding obligation upon the vesting and issuance of RSUs. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.41 to $16.56, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 20, 2014. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.73 to $15.01, inclusive. The Reporting Person undertakes to provide to Sangamo BioSciences, Inc., any security holder of Sangamo BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. These shares are held in the Edward O. Lanphier II and Cameron M. Lanphier Trust U/T/A August 30, 2002, Edward O. Lanphier II and Cameron M. Lanphier, Trustees. The stock option vests and becomes exercisable for 25% of the shares upon the Reporting Person's completion of one year of service measured form the grant date, and the balance of the shares will vest and become exercisable in 36 successive equal monthly installments upon his completion of each additional month of service thereafter. All shares underlying these options are vested and exercisable immediately and such option will expire on December 11, 2015. /s/ Florence Tam, attorney-in-fact 2014-12-15